Tag: biomarker

As many as 75% of PSA tests come back falsely positive, and for years that single number sent men straight to a needle biopsy with all its risks. Today, noninvasive biomarker tests in blood and urine, paired with mpMRI, are reshaping who truly needs the procedure and who can safely be spared the discomfort and the worry. keep reading

Artificial Intelligence is reshaping prostate cancer care, from more accurate screening and early detection to optimizing treatment strategies. New research highlights four major clinical areas where AI is already making a measurable difference in diagnosis, risk assessment, and therapy planning. keep reading

Can a cancer diagnosis bring a sense of relief? For men with prostate cancer caught at Grade Group 1, emerging research and expert protocols suggest that aggressive treatments can often be avoided. Active surveillance, targeted focal therapies, and more precise diagnostic tools are helping many choose paths that spare quality of life. keep reading

UPDATE: 11/21/2025 Originally published Mar. 11, 2024 The blog below announced news that before radical prostatectomy (RP), multiparametric MRI findings can predict if a prostate cancer (PCa) patient is at risk of recurrence after RP. Prior to MRI predictions, the CAPRA-S score had become the gold standard for predicting biochemical recurrence risk—but only after the surgery was done. Thus, keep reading

What happens when cutting-edge MRI isn’t within reach for prostate cancer screening? A simple blood test now promises to cut needless biopsies and healthcare costs. The Stockholm3 test combines genetic, protein, and clinical markers to fine-tune prostate cancer detection—potentially sparing men invasive procedures. keep reading

What does it mean when PSA levels rise after prostate cancer treatment—even years later? For many men, that first hint of a change can be both unsettling and significant. Catching biochemical recurrence early with scheduled PSA testing remains one of the most effective ways to stay ahead of potential cancer activity. keep reading

Researchers are advancing smarter prostate cancer screening methods. A new biomarker test, combined with advanced MRI techniques, could improve early detection of high-grade prostate cancers and reduce the need for unnecessary procedures, offering more accurate and reliable diagnosis. keep reading

“Out of all the stars labeled Box Office Poison by the Independent Theater Owners Association in 1938, Katharine Hepburn is one who maintains a high degree of name recognition today…” This is the opening sentence of a January 2023 article in Hollywood Revue, explaining how the Great Kate was dealt a blow to her reputation—a keep reading

There used to be an off-price clothing store called Syms, described by one journalist as “unlike any department store I’ve seen before or since.” If you were a savvy shopper, Syms was the place for you. Their slogan, “An educated consumer is our best customer,” was one of the greatest in retail history! Today’s prostate keep reading

When it comes to prostate cancer, your body comes equipped with a kind of check engine light. It’s your PSA blood test. If it comes back abnormally high or rising, it’s a physical uh-oh. Like a check engine light, it doesn’t tell you exactly what the problem is. A doctor’s next step might well be a conventional 12+ core, with its risks of inaccuracy and side effects. What if there were a simpler way to assemble and evaluate vital information in a single step, such as a blood draw? keep reading